MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 18, 2006; DOI: 10.1124/mol.106.030684


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.030684v1
71/3/949    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreau, M. E.
Right arrow Articles by Marceau, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreau, M. E.
Right arrow Articles by Marceau, F.


Received for publication September 8, 2006.
Revised November 23, 2006.
Accepted for publication December 18, 2006.

Role of NF-{kappa}B and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells

Marie Eve Moreau 1, Marie-Therese Bawolak 2, Guillaume Morissette 2, Albert Adam 1, Francois Marceau 3*

1 U. of Montreal 2 CHUL-CHUQ 3 Centre Hospitalier Universitaire de Quebec

* Address correspondence to: E-mail: francois.marceau{at}crchul.ulaval.ca

Abstract

Kinin B1 receptor expression was characterized in human umbilical artery smooth muscle cells to further elucidate the function and specificity of 3 previously proposed pathways (NF-{kappa}B, protein kinase C, agonist autoregulation) that regulate this inducible G protein-coupled receptor. Radioligand binding assays, real time RT-PCR with an optional actinomycin D treatment period and NF-{kappa}B immunofluorescence were primarily employed in these primary cell cultures. Various stimulatory compounds that increase receptor mRNA stability only (human and bovine sera, cycloheximide) or that stimulate NF-{kappa}B nuclear translocation and both mRNA concentration and stability (IL-1{beta}, phorbol 12-myristate 13-acetate [PMA]) all increased the density of binding sites for the tritiated B1 receptor agonist [3H]Lys-des-Arg9-bradykinin (without change in receptor affinity) in cell-based assays. Small interfering RNA (siRNA) assays indicated that NF-{kappa}B p65 is necessary for the effective expression of the cell surface B1 receptor under basal or IL-1{beta}, FBS, or PMA stimulation conditions. Dexamethasone cotreatment reproduced these effects. IL-1{beta}-, FBS-, or PMA-induced stabilization of B1 receptor mRNA was inhibited by the addition of the protein kinase C inhibitor GF109203x, which also diminished the Bmax under FBS or PMA treatment. Lys-des-Arg9-bradykinin had little effect on NF-{kappa}B activation, the Bmax, or receptor mRNA abundance or stability. Both NF-{kappa}B and protein kinase C signaling are required for the effective expression of the kinin B1 receptor in human umbilical artery smooth muscle cells.


Key words: Bradykinin, Interleukins, Protein Kinase C, Receptor synthesis/trafficking, NFkappaB


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M.-T. Bawolak, L. Gera, G. Morissette, J. Bouthillier, J. M. Stewart, L.-A. Gobeil, R. Lodge, A. Adam, and F. Marceau
Fluorescent Ligands of the Bradykinin B1 Receptors: Pharmacologic Characterization and Application to the Study of Agonist-Induced Receptor Translocation and Cell Surface Receptor Expression
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 159 - 168.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics